The Medicines Patent Pool was established in 2010 and comprises a team of dedicated staff, the Governance Board, the Expert Advisory Group, the Scientific Advisory Panel and Community Advisory Panel.
Array ( [0] => Array ( [acf_fc_layout] => text_editor_block [text_editor] => MPP’s goals and governance procedures are outlined in our Statutes, available in English and French. The duties of the Governance Board, the Expert Advisory Group (EAG), the Scientific Advisory Panel (SAP), and the Community Advisory Panel (CAP) and their relationship with MPP, are described in the Medicines Patent Pool by-laws and in the EAG Terms of Reference, SAP Terms of Reference and CAP Terms of Reference, MPP operates in an accountable manner, in accordance with our transparency policy. [text_editor_styles] => Array ( [alignment] => left [text_colour_font] => text-default [background_colour] => false [background_image] => [background_image_style] => center / cover no-repeat [overlay_colour] => false ) ) [1] => Array ( [acf_fc_layout] => page_tabs [tab_style] => tabs [tab_section_background_colour] => false [tabs] => Array ( [0] => Array ( [tab_name] => Governance Board [tab_image] => [show_posts] => [posts] => Array ( [show_latest_posts] => [posts_to_display_in_grid] => [number_of_posts_to_show] => -1 [post_type] => news-publications [news_publication_type] => [people_type] => [company_type] => [show_events_from_date] => all ) [tab_content] => Array ( [0] => Array ( [acf_fc_layout] => single_column [blocks] => Array ( [0] => Array ( [acf_fc_layout] => text_editor_block [text_editor] => The Governance Board is MPP’s governing body and its highest authority for making decisions (see our statutes). Among its key duties are to set MPP’s policies and strategies, oversee its work plan and financial matters, and monitor and evaluate its performance. The Governance Board recognises that its ability to formulate sound decisions for the organisation is improved by the diversity of its membership. As such, the Board is actively committed to a composition that is diverse and inclusive, including a balance of sex and gender, race, age, geographic location, skills and experience, while ensuring that each individual member is an expert in their field, committed to the public interest, and dedicated to MPP’s mission. Governance Board Decisions The Governance Board also appoints the Executive Director and Governance Board members. MPP’s Executive Director attends Governance Board meetings, but without a right to vote. Since 1 September 2017, the Chair of the Governance Board is Marie-Paule Kieny. [text_editor_styles] => Array ( [alignment] => left [text_colour_font] => text-default [background_colour] => false [background_image] => [background_image_style] => center / cover no-repeat [overlay_colour] => false ) ) [1] => Array ( [acf_fc_layout] => post_grid [show_latest_posts] => [post_grid_layout] => rectangular [background_colour] => bg-white [posts_per_row] => 4 [posts_to_display_in_grid] => Array ( [0] => WP_Post Object ( [ID] => 791 [post_author] => 1 [post_date] => 2020-04-06 15:14:44 [post_date_gmt] => 2020-04-06 14:14:44 [post_content] => [post_title] => Marie-Paule Kieny [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => marie-paule-kieny [to_ping] => [pinged] => [post_modified] => 2024-05-23 11:23:51 [post_modified_gmt] => 2024-05-23 09:23:51 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=791 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 16957 [post_author] => 6 [post_date] => 2024-05-13 10:59:48 [post_date_gmt] => 2024-05-13 08:59:48 [post_content] => [post_title] => Grégory Bonnaud [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => gregory-bonnaud [to_ping] => [pinged] => [post_modified] => 2024-05-13 11:19:21 [post_modified_gmt] => 2024-05-13 09:19:21 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=16957 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 16953 [post_author] => 6 [post_date] => 2024-05-13 10:33:23 [post_date_gmt] => 2024-05-13 08:33:23 [post_content] => [post_title] => Maureen Luba [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => maureen-luba-2 [to_ping] => [pinged] => [post_modified] => 2024-05-13 10:33:23 [post_modified_gmt] => 2024-05-13 08:33:23 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=16953 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) [3] => WP_Post Object ( [ID] => 7963 [post_author] => 14 [post_date] => 2020-12-01 15:40:23 [post_date_gmt] => 2020-12-01 15:40:23 [post_content] => [post_title] => Mojisola Christianah Adeyeye [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => mojisola-christianah-adeyeye [to_ping] => [pinged] => [post_modified] => 2020-12-01 15:40:23 [post_modified_gmt] => 2020-12-01 15:40:23 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=7963 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) [4] => WP_Post Object ( [ID] => 8581 [post_author] => 14 [post_date] => 2021-04-01 08:00:07 [post_date_gmt] => 2021-04-01 07:00:07 [post_content] => [post_title] => Peter Maybarduk [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => peter-maybarduk [to_ping] => [pinged] => [post_modified] => 2021-03-31 14:03:22 [post_modified_gmt] => 2021-03-31 13:03:22 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=8581 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) [5] => WP_Post Object ( [ID] => 15648 [post_author] => 20 [post_date] => 2023-11-01 11:45:49 [post_date_gmt] => 2023-11-01 10:45:49 [post_content] => [post_title] => Govindarajan Narayanan [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => govind-narayanan [to_ping] => [pinged] => [post_modified] => 2025-02-05 17:53:57 [post_modified_gmt] => 2025-02-05 16:53:57 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=15648 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) [6] => WP_Post Object ( [ID] => 9635 [post_author] => 6 [post_date] => 2021-10-15 10:17:20 [post_date_gmt] => 2021-10-15 09:17:20 [post_content] => [post_title] => Maximiliano Santa Cruz [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => maximiliano-santa-cruz [to_ping] => [pinged] => [post_modified] => 2021-10-15 10:17:20 [post_modified_gmt] => 2021-10-15 09:17:20 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=9635 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) [7] => WP_Post Object ( [ID] => 12358 [post_author] => 20 [post_date] => 2022-09-01 08:20:19 [post_date_gmt] => 2022-09-01 07:20:19 [post_content] => [post_title] => Pushpa Vijayaraghavan [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => pushpa-vijayaraghavan [to_ping] => [pinged] => [post_modified] => 2025-06-20 15:52:04 [post_modified_gmt] => 2025-06-20 13:52:04 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=12358 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) [8] => WP_Post Object ( [ID] => 19208 [post_author] => 21 [post_date] => 2025-03-05 12:41:27 [post_date_gmt] => 2025-03-05 11:41:27 [post_content] => [post_title] => Dr Ntobeko Ntusi [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => dr-ntobeko-ntusi [to_ping] => [pinged] => [post_modified] => 2025-03-06 11:25:49 [post_modified_gmt] => 2025-03-06 10:25:49 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=19208 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) [9] => WP_Post Object ( [ID] => 10925 [post_author] => 6 [post_date] => 2022-02-14 09:12:43 [post_date_gmt] => 2022-02-14 09:12:43 [post_content] => [post_title] => Philippe Duneton [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => philippe-duneton [to_ping] => [pinged] => [post_modified] => 2022-02-18 13:29:22 [post_modified_gmt] => 2022-02-18 13:29:22 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=10925 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) [10] => WP_Post Object ( [ID] => 8232 [post_author] => 14 [post_date] => 2020-12-22 14:50:59 [post_date_gmt] => 2020-12-22 14:50:59 [post_content] => [post_title] => Amy Dietterich [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => amy-dietterich [to_ping] => [pinged] => [post_modified] => 2020-12-22 14:50:59 [post_modified_gmt] => 2020-12-22 14:50:59 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=8232 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) [11] => WP_Post Object ( [ID] => 15459 [post_author] => 20 [post_date] => 2023-09-21 06:41:08 [post_date_gmt] => 2023-09-21 04:41:08 [post_content] => [post_title] => Dr Yukiko Nakatani [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => dr-yukiko-nakatani [to_ping] => [pinged] => [post_modified] => 2023-09-21 06:58:27 [post_modified_gmt] => 2023-09-21 04:58:27 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=15459 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) [12] => WP_Post Object ( [ID] => 19013 [post_author] => 21 [post_date] => 2025-02-07 11:51:44 [post_date_gmt] => 2025-02-07 10:51:44 [post_content] => [post_title] => Johanna Hill [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => johanna-hill [to_ping] => [pinged] => [post_modified] => 2025-02-10 12:38:41 [post_modified_gmt] => 2025-02-10 11:38:41 [post_content_filtered] => [post_parent] => 0 [guid] => https://medicinespatentpool.org/?post_type=people&p=19013 [menu_order] => 0 [post_type] => people [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [number_of_posts_to_show] => -1 [post_type] => people [disease_styles] => [news_publication_type] => [people_type] => Array ( [0] => WP_Term Object ( [term_id] => 28 [name] => Governance Board [slug] => governance-board [term_group] => 0 [term_taxonomy_id] => 28 [taxonomy] => people-type [description] => [parent] => 25 [count] => 1 [filter] => raw ) ) [company_type] => [include_filters] => [show_images] => 1 [show_events_from_date] => all ) [2] => Array ( [acf_fc_layout] => text_editor_block [text_editor] => MPP’s Past Chairs [text_editor_styles] => Array ( [alignment] => left [text_colour_font] => text-default [background_colour] => false [background_image] => [background_image_style] => center / cover no-repeat [overlay_colour] => false ) ) ) ) ) ) [1] => Array ( [tab_name] => Expert Advisory Group [tab_image] => [show_posts] => [posts] => Array ( [show_latest_posts] => [posts_to_display_in_grid] => [number_of_posts_to_show] => -1 [post_type] => news-publications [news_publication_type] => [people_type] => [company_type] => [show_events_from_date] => all ) [tab_content] => Array ( [0] => Array ( [acf_fc_layout] => single_column [blocks] => Array ( [0] => Array ( [acf_fc_layout] => text_editor_block [text_editor] => The Expert Advisory Group (EAG) advises the Governance Board and the Executive Director on MPP’s licence negotiations, and assesses whether the terms and conditions of the proposed licence agreements meet the key requirements as set out by MPP’s Statutes. Individual members of the EAG are also consulted by the Executive Director in their particular area of expertise that is relevant to the work of MPP. In selecting the members of the EAG, the Governance Board has sought to bring in expertise in the following areas, while achieving an appropriate geographical and gender balance:
MPP’s goals and governance procedures are outlined in our Statutes, available in English and French. The duties of the Governance Board, the Expert Advisory Group (EAG), the Scientific Advisory Panel (SAP), and the Community Advisory Panel (CAP) and their relationship with MPP, are described in the Medicines Patent Pool by-laws and in the EAG Terms of Reference, SAP Terms of Reference and CAP Terms of Reference, MPP operates in an accountable manner, in accordance with our transparency policy.
The Governance Board is MPP’s governing body and its highest authority for making decisions (see our statutes). Among its key duties are to set MPP’s policies and strategies, oversee its work plan and financial matters, and monitor and evaluate its performance.
The Governance Board recognises that its ability to formulate sound decisions for the organisation is improved by the diversity of its membership. As such, the Board is actively committed to a composition that is diverse and inclusive, including a balance of sex and gender, race, age, geographic location, skills and experience, while ensuring that each individual member is an expert in their field, committed to the public interest, and dedicated to MPP’s mission.
Governance Board Decisions
The Governance Board also appoints the Executive Director and Governance Board members. MPP’s Executive Director attends Governance Board meetings, but without a right to vote. Since 1 September 2017, the Chair of the Governance Board is Marie-Paule Kieny.
MPP’s Past Chairs
The Expert Advisory Group (EAG) advises the Governance Board and the Executive Director on MPP’s licence negotiations, and assesses whether the terms and conditions of the proposed licence agreements meet the key requirements as set out by MPP’s Statutes.
Individual members of the EAG are also consulted by the Executive Director in their particular area of expertise that is relevant to the work of MPP.
In selecting the members of the EAG, the Governance Board has sought to bring in expertise in the following areas, while achieving an appropriate geographical and gender balance:
Members of the EAG act solely in their personal capacity.
The EAG reports on MPP’s licences are publicly available as stated in our transparency policy.
Access the EAG Terms of Reference.
The Scientific Advisory Panel (SAP) was created in 2019 to support the work of the Expert Advisory Group (EAG). The panel, composed of a pool of subject-matter experts, provides MPP and its governing bodies with critical insights and guidance. Access the SAP Terms of Reference
The Community Advisory Panel (CAP) is a mechanism that serves a key advisory role in providing MPP and the MPP Expert Advisory Group (EAG) with critical insights and guidance from its members’ lived experiences. Access the CAP Terms of Reference.
The mRNA Scientific Advisory Committee (mSAC) is an independent committee convened by the Medicines Patent Pool (MPP) to deliver answers, on a consultative basis, to specific questions on scientific matters addressed to them relating to the mRNA Technology Transfer Hub Programme.
Composition of m-SAC as of September 2022, with more members coming soon
Office Assistant (Mumbai)
Head of Alliance and India Office (Mumbai)
Aditi Das joined the Medicines Patent Pool in January 2021 as Business Development Manager, Technical and Regulatory Affairs, at the Indian Liaison Office in Mumbai. In 2024, Aditi became the Head of Alliance and India Office. Aditi supports the Business Development team with respect to the technical and regulatory aspects of drug product development. Aditi has a rich experience of 18 years in diverse areas of drug product development including formulation and process development, technology transfer and Quality by Design across several organisations including Glenmark Pharmaceuticals, Sandoz, Novartis, and Zydus Pharmaceuticals. Prior to joining MPP, Aditi was heading the Centre of Excellence for topical products for Zydus Pharmaceuticals. Aditi holds a master’s degree in Pharmaceutical Sciences from Banaras Hindu University, India.
Business Development – Alliance Manager (Geneva)
Meghmala Das is a Business Development Manager and joined the Medicines Patent Pool in October 2017. At MPP, she is responsible for alliance and partnership management in addition to analysing data for monitoring progress of projects. She brings a wealth of experience in data analysis and project management to this role having worked previously at Axtria in pharmaceutical analytics and the economics affairs department of Federation of Indian Chambers of Commerce and Industry (FICCI). Meghmala holds a bachelor’s degree in business studies and a master’s degree in business economics, both from the University of Delhi.
Manager, Scientific and Medical Affairs (Geneva)
Prior to joining MPP, Romain has worked in medical research, conducting projects on kidney diseases in France, Scotland, and Switzerland. More recently, he worked for the NCD Alliance where he was responsible for strategic engagement with multilateral partners, corporations, foundations, and NGOs. He holds a Master’s degree in health biology and a PhD in pharmacology from the University of Toulouse.
Head of Scientific and Medical Affairs (Geneva)
Lobna Gaayeb is the Head of Scientific and Medical Affairs at the Medicines Patent Pool Foundation, overseeing the selection and monitoring of in-licensing medicine efforts. Since joining in 2019, she has focused on licensing long-acting health technologies and established the LAPaL database for these innovations. With previous roles at Institut Pasteur managing the MediLabSecure network and experience in infectious disease research, Lobna applies her expertise in veterinary science, clinical research, and public health to improve global health initiatives. She holds a Master’s in Biology and a Ph.D. in Clinical Research, Technological Innovation, and Public Health. She speaks five languages, leveraging her linguistic skills and cultural understanding in her work.
Product Development Technical Expert
Bhushan Katkade joined MPP as a Product Development Technical Expert in October 2024. He acts as a subject matter expert for product development and related technical areas within MPP.
With 18 years of broad pharmaceutical industry experience, Bhushan has gained proficiency in Quality by Design based product as well as process design and development along with technology transfer of various pharmaceutical dosage forms such as transdermal, oral, topical, and sterile ophthalmic while working across several organisations including Mylan, Sandoz, Akorn (at U.S. locations), and Encube Ethicals and Galentic Pharma in India.
Prior to joining MPP, Bhushan was heading R&D at Galentic Pharma (India) Pvt. Ltd. He is multi-lingual and enjoys working in a multi-cultural environment.
Bhushan is a registered pharmacist and holds a Bachelor of Pharmacy from University of Mumbai and a Master of Science in Pharmaceutical Sciences from Northeastern University (Boston, USA).
Business Development Manager, In-licensing (Geneva)
Parag Nimbolkar joined the Medicines Patent Pool as a Business Development Manager in May 2022 where he is responsible for the in-licensing activities at MPP. In this role, Parag brings private sector experience in business development and licensing. Parag has over 10 years of experience in a variety of fields such as the licensing of biosimilars and injectable and generic products, corporate strategy and M&A’s, market access and portfolio management.
Parag has worked with IQVIA, Dr. Reddy’s and more recently with Intas Pharmaceuticals. Parag holds a Master of Pharmaceutical Management from NIPER, Mohali, India and a Bachelor of Pharmacy from the University of Pune, India.
Business Development, Alliance Manager (Mumbai)
Shambhavi Warerkar Pai joined MPP in May 2023 as Business Development – Alliance Manager at the Indian Liaison Office. At MPP, she is responsible for alliance management with generic manufacturers (MPP licensees). Shambhavi has over 11 years of rich experience in the pharma industry in various domains, such as API and Formulation exports, In-licensing and out-licensing of generics, business development and project management. She has worked for Indoco Remedies, Enaltec Labs, Sai Lifesciences Limited, and CBC Corporation (India) Private Limited. Shambhavi holds a Bachelor’s in pharmacy from Pune University and Post Graduate Diploma in Operations Management from Symbiosis International University.
Senior Manager, Scientific and Medical Affairs (Geneva)
Manuele Piccolis joined the Medicines Patent Pool as Scientific Manager for Infectious Diseases in March 2020. He holds a PhD in Life Sciences from the University of Geneva and he has an extensive experience in metabolism. Before joining MPP, Manuele worked at the Gladstone Institutes (CA), Harvard HSPH (MA), EPFL (CH). More recently he was responsible for the clinical evaluation of Rapid Diagnostic Test for infectious diseases in LMIC. In MPP, he joined the Business Development team bringing his scientific expertise in the evaluation of treatments that are candidates for in-licensing.
Maneesha Ranaut joined MPP in February 2019 as an Executive Assistant at the Indian Liaison Office. In July 2021, she transitioned into the role of Project Manager-Business Development, where she was managing internal relationships for the Business Development Team and also aiding out-licensing management activities. In April 2023, Maneesha stepped into the role of Alliance Manager, taking charge of managing alliances with the generic manufacturers (MPP Licensees). Before her tenure at MPP, she was associated with Wilhelm Fricke as an Executive Assistant and Logistics Manager. Her multifaceted experience coupled with a background in Oberoi Hotels and Resorts, has provided her with valuable insights into the hospitality industry. Maneesha holds a Bachelor’s in Science from Himachal Pradesh University and a Master’s in Operations Management from Jaipur National University.
Ashok Valechha joined MPP in March 2022 as Business Development – Alliance Manager at the Indian Liaison Office. At MPP, he is responsible for alliance management with generic manufacturers (MPP licensees). Ashok comes with 15 years of rich experience in pharma industry with a knowledge of generic pharmaceutical product development, project management and business development, having worked for companies such as Famy Care & Zydus Cadila. Prior to joining MPP, he was heading the Project Management function at Bliss GVS Pharma Ltd. Ashok holds a Bachelor’s in pharmacy and Post Graduate Diploma in Business Management from Mumbai University.
Business Development, Alliance Manager (Geneva)
Valentina Lee joined the Medicines Patent Pool in November 2023, in our Geneva Office, as Business Development – Alliance Manager, focusing on MPP’s relationships with our licensors. With a Bachelor’s in Life Sciences and Biotechnology and a Master’s in Industrial Pharmaceutical Science, she brings over eight years of experience from Celltrion, Inc., a key MPP sublicensee. Her expertise spans formulation development projects and business management in low- and middle-income countries. Valentina’s commitment to leveraging her pharmaceutical industry experience for public health highlights her dedication to improving global access of essential medicines, embodying MPP’s mission to serve communities in need.
Regulatory Affairs Specialist (Mumbai)
Kajal Patil joined MPP in December 2024 as a Regulatory Affairs Specialist. With 14 years of experience in the pharmaceutical field, she holds a M.Sc. in Chemistry and a Postgraduate Diploma in Drug Regulatory Affairs. Before joining MPP, she was associated with organisations such as Glenmark Pharmaceuticals, Indoco Remedies, Cipla Limited, and Genpact India Pvt Ltd. At MPP, her role focuses on collecting and analysing regulatory guidance and legislation from various low- and middle-income countries She summarises the data for a regulatory database and collaborates with the IP team to maintain relevant information. She also monitors regulatory changes and ensures the database is regularly updated.
Business Development and In-Licensing Manager
Communications Director (Executive Leadership Team)
Gelise McCullough, our Communications Director (Executive Leadership Team) joined the Medicines Patent Pool in January 2020. Gelise is a public health professional with 20 years of experience. She has come from Unitaid where she worked for nearly 12 years in programme management and communication on range of innovative grants including intellectual property. She is dedicated to access to treatment and has worked with a wide range of partners, international, government and civil society, to ensure quality, adapted and affordable medicines and diagnostics are made available to those who need it most. She enjoys fostering partnerships and engaging stakeholders towards a common goal. Gelise has worked in communication roles with a number of International Organisations: United Nations Development Program (UNDP), World Health Organization (WHO), UNICEF. Gelise holds a Master’s in Public Health from the London School of Hygiene and Tropical Medicine, where she specialised in health promotion. Her first degree was in Communications.
Communications Officer
Héloïse Therrat joined us in January 2025 as a Communications Officer. With a solid background in design, content creation, and strategic communication, she brings valuable expertise to our team. Previously, Héloïse served as a Communication and Webmaster Officer at the Embassy of France in Washington, DC, for two years. In this role, she managed digital campaigns, developed the “France Science” visual identity, and created marketing materials to support collaborations between French and American scientists. Before that, she gained experience at CNRS in Lyon, France, working with the Laboratory of Excellence ASLAN. There, she managed digital content and social media. Héloïse holds a Master’s degree in Prospective Design from the University of Saint-Étienne, France, and a Bachelor’s degree in Advertising and Marketing Communications from Technological University Dublin, Ireland.
Senior Communications Manager
Sophie Thievenaz is our Senior Communications Manager since October 2016, overseeing digital communications at MPP, media relations, as well as events and publications. She also works closely with the Head of Communications to implement our communications strategy. Sophie acted as Head of Communications a.i. from June-December 2019. Sophie comes with a wealth of communications and advocacy experience, having served as Communications Officer for the Sanitation and Water for All Global Partnership, hosted by UNICEF in Geneva. Here, Sophie managed the organisation’s web and social media presence, publications and events. She also worked as the Communications and Campaign Coordinator for Yfoundations, a non-profit organisation working to address youth homelessness in Sydney, Australia, and for the Chamber of Commerce and Industry in Annecy, France. Sophie has a master’s degree in political science from the Institut d’Etudes Politiques d’Aix-en-Provence, a postgraduate diploma in corporate social responsibility from the London Metropolitan Business School, UK, and a certificate on patent law and global public health from Havard Law School.
Partnerships and Media Relations Manager for the Technology Transfer Hub (Expertise France)
Communications Manager
Shihan Liu joined the Medicines Patent Pool (MPP) in July 2025 as Communications Manager. She is a seasoned communications specialist with over 10 years of experience in strategic communications, risk communication, public health advocacy, partnership development, and multimedia production. Shihan has worked with several United Nations agencies, including the World Health Organization (WHO), the UN Refugee Agency (UNHCR), as well as with Spanish television, contributing to a wide range of global public health and humanitarian initiatives. Shihan holds a master’s degree in Audiovisual Communications and Advertising from the Autonomous University of Barcelona. Originally from China, she is based in Geneva, Switzerland.
General Counsel (Executive Leadership Team)
Chan Park is the Medicines Patent Pool’s General Counsel (Executive Leadership Team). He has been with MPP since it was established in 2010, overseeing all legal matters of the organisation. As General Counsel, Chan forms a vital part of our negotiation team, and has successfully negotiated and drafted our licensing agreements. Before joining MPP, Chan was a member of the team at Unitaid that conceptualised and established our organisation. An attorney by training, Chan practised IP law with US firm, Wilson Sonsini Goodrich and Rosati, and served as Senior Technical and Policy Advisor for the Lawyers Collective HIV/AIDS unit in India. He has consulted for a number of international organisations, including the United Nations Development Programme, the World Health Organization and Unitaid, on a range of issues related to IP and access to medicines. Chan received his Bachelor of Arts from the University of Pennsylvania, USA and his Juris Doctor from the New York University School of Law, USA.
Associate Counsel
Bryce Robinson is an Associate Counsel at the Medicines Patent Pool. Prior to joining MPP, Bryce practised as an intellectual property litigator at a global law firm, Herbert Smith Freehills, and has particular experience in patent disputes in the pharmaceutical, life sciences, and technology sectors. He has also worked as a health law researcher for non-profit and academic institutions in the USA. Bryce holds a Master of Laws in National & Global Health Law from Georgetown University (USA) and a Bachelor of Laws (Honours), Bachelor of Science, and Diploma of Languages from the Australian National University.
Paralegal Officer
Razan Walch joined the Medicines Patent Pool in September 2022 as Paralegal Officer, where she manages contracts and assist in the implementation of compliance processes, as well as assist on a variety of MPP legal matters.
Razan brings over 10 years of professional experience in corporate law, legal research and contracts management. She has worked in multinational companies in sectors such as healthcare services, supply of industrial gases, and water management technologies.
Razan holds a degree in paralegal studies from the University of Sharjah in UAE and Bachelor of Arts from Yarmouk University in Jordan.
Chief Operating Officer (Executive Leadership Team)
Jane Caldwell, our Chief Operating Officer (Executive Leadership Team), joined MPP in August 2022, overseeing finance, human resources, IT and resource mobilisation. She brings substantial experience of organisation effectiveness, partnerships and income generation working in the non-profit sector for 13 years most recently as a CEO. Previously, Jane worked as a film producer making human rights documentaries and feature films in Europe, Asia and America. She has supported the start-up of three businesses in different sectors including the Greentech industry and was a founding member of the Women’s Equality Party where she raised the funds to launch this new political party in the UK. Jane has a post-graduate qualification in Health Economics and Policy from the London School of Economics and Political Science (LSE).
Office Manager
Victoria holds a degree in foreign languages (French and English) and in psychology. She brings more than 20 years of experience in project management, event organisation and as assistant. Victoria has a strong experience in the public health sector having worked for Doctors without borders, the AIDS foundation East-West. Her work experience includes also work at the Embassy of France to Ukraine and Twinning project on the Early intervention system for children with disabilities realised with Expertise France and Ministry of Social Affairs.
Senior Finance Officer
Gerry Fayolle joined the Medicines Patent Pool in June 2022 as Finance and Administration Officer. In April 2024, Gerry was promoted as Senior Finance Officer. As an accountant he’s mainly in charge of supplier invoices, professional expenditures and payment. Gerry hold the Baccalaureate in finance and accountancy, the technician brevet in management and accountancy and a license in finance and administration, moreover brings almost 4 years as a Junior Accountant for several companies, handling customers and suppliers bookkeeping.
Monitoring and Evaluation Manager
Ruth Foley joined MPP as Monitoring and Evaluation Manager in June 2021. She brings with her 19 years of experience in the NGO sector, with specific expertise in monitoring, evaluation and strategy development as well as in advocacy on human rights, gender equality and HIV. Previous employers include the International Committee of the Red Cross (ICRC) and the Lutheran World Federation (LWF). Ruth holds a Master in International Affairs from the Graduate Institute in Geneva and a Bachelor of Arts (BA) in Oriental Studies from the University of Cambridge.
Resource Mobilisation & Grants Manager
Vittorio Giorgetti has joined MPP as Grants and Operations Manager in February 2023. Vittorio will work to ensure the efficient management of grants and donor relations, as well as the delivery of the strategic implementation plan. His career started in 2015 at the Brussels’ office of A.R.S. Progetti, where he was appointed as grant officer and writer of project proposals. He moved to Geneva in 2018 and he started working as independent consultant in the fields of fundraising and grant management. His services were addressed to Universities, centers of research, NGOs, and start-ups based in several EU countries. Vittorio holds a master’s degree in international Relations and European Studies from the ‘Cesare Alfieri’ School of Florence.
Human Resources Manager
Gosha Stehle joined MPP in September 2022 as HR Manager. Before joining MPP she worked in nonprofit organizations in Geneva performing various business support functions including, human resources, finance and administration, governance, and projects support. Gosha holds master`s degree in American studies and certification in human resources management from the HRSE Swiss Exams. Originally from Poland, she lived and worked in the United Kingdom before relocating to Geneva.
Senior Manager, Grants and Governance
Agnese joined the Medicines Patent Pool as Grants and Operations Manager in November 2020. In April 2024, Agnese was promoted as Senior Manager, Grants and Governance. Agnese supports her department in ensuring the smooth running of the day-to-day operations of the organisation and the efficient management of grants and donor relations. Agnese is genuinely committed to work for organisations that ensure access to equal opportunities for all. She has worked in the non-profit sector for nearly 8 years as Programme Finance Associate, Afghanistan for the International Development Law Organization, as Project Officer, Somalia for the International Fund for Agricultural Development (IFAD), and most recently as Officer, Operational efficiency at the Global Fund. She holds a Master of Science degree in International Management from King’s College, London and a Bachelor of Arts from John Cabot University in Rome.
Finance Manager
Policy, Strategy and Market Access Director (Executive Leadership Team)
Esteban Burrone is our Policy, Strategy and Market Access Director (Executive Leadership Team). Esteban has been with us since we were established, in 2010, and oversees our strategy development and our partnerships with a wide range of external organisations. These include governments, intergovernmental organisations, public health organisations, civil society and community-based organisations. He is part of our senior management team and has overall responsibility for our Patents and Licences Databases (MedsPaL and VaxPaL). Esteban has more than 20 years of experience working in the field of innovation, IP rights and access to medicines. Esteban holds a Master of Science in Development Studies from the London School of Economics, a Master in Business Administration from the International University in Geneva and a Master in Public Health from the London School of Hygiene and Tropical Medicine.
Policy and Advocacy Manager
Tiwadayo Braimoh joined the Medicines Patent Pool in February 2022 as Policy and Advocacy Manager after about 20 years of work across sectors and areas including the pharmaceutical industry, public health, and health policy. He started off his career playing different roles progressively in sales, marketing, and business development in the pharmaceutical industry, then joined Clinton Health Access Initiative (CHAI) where he worked on access programs and with governments in Africa on various health policy issues. Just before joining MPP, he was Senior Technical Advisor for Health Financing at the Ministry of Health, Rwanda, where he worked closely with high level stakeholders across sectors on health systems strengthening and on an African Union’s continental health financing initiative. At MPP, he leads on the policy aspects of COVID-19 and pandemic preparedness, and on Africa. Tiwadayo holds an MSc in Health Policy, Planning and Financing from London School of Economics and London School of Hygiene and Tropical Medicines and an MBA from the University of Lagos. He is also a Pharmacist and Fellow of the West African Postgraduate College of Pharmacists.
Head of Patent Information
Amina Larbi joined the Medicines Patent Pool in September 2018 as Patent Information Manager. Part of the Policy and Advocacy team, she manages the patent and information team responsible of maintaining and developing MPP’s Patents and Licences Databases and performing patent searches and analyses. Amina is a registered Swiss and European Patent Attorney with a broad experience as a patent specialist in the private sector, particularly in the field of biopharmaceuticals. Her experience extends from prior-art searching, performing patentability studies, patent drafting and prosecution, handling of patent and trademark portfolios to the management of intellectual property databases and systems. Before joining the MPP, Amina worked for five years for two companies active in the field of mechanics (medical devices, optics, security printing) after having worked for 14 years in the Intellectual of Property Department of the pharmaceutical company Merck-Serono S.A, based in Geneva. Amina holds a master’s degree in biology from the University of Geneva.
Policy and Advocacy Officer
Marie Levy joined the Medicines Patent Pool in October 2022 as Policy and Advocacy Officer. She has mostly been working on external relations, advocacy, and partnership management for international organisations, both at HQ and field level. Before joining MPP Marie worked at Unitaid, the European Commission and the French national institute for health and medical research (INSERM).
She holds master’s degrees in international humanitarian law and political sciences and has a particular interest in access to health and social justice.
Senior Manager, Policy, Strategy and Market Access
Mila Maistat joined the Medicines Patent Pool in May 2017 as a Policy and Advocacy Manager. She has over 20 years of experience in public health, specifically in policy and access to medicines. In April 2024, she was promoted to Senior Manager, Policy, Strategy, and Market Access. Mila’s work covers various disease areas, including HIV and viral hepatitis, with a focus on WHO Europe, SEARO, and WPRO regions. She collaborates with a wide range of stakeholders, including governments, intergovernmental and public health organisations, civil society, and community-led organisations.
Before joining MPP, Mila was a Senior Manager and Program Advisor at the Alliance for Public Health, leading policy activities for viral hepatitis programs. She has served on WHO committees and the Lancet Commission on Viral Hepatitis. Recognised by The Economist as a leading advocacy voice, Mila also served on the Unitaid NGO delegation and remains active in several international health committees.
Mila holds a Master of Arts in English and German languages and literatures from Gogol National University, a Master of Science in Social Sciences and Technologies from the National University of Kyiv-Mohyla Academy, a Master of Public Health from the London School of Hygiene and Tropical Medicine, and several diplomas in intellectual property from WIPO. She speaks Ukrainian, English, French, German, and Russian.
Senior Manager – Policy, Strategy and Market Access
Patent Information Specialist
Dana Mozaffari joined MPP in December 2024 as Patent Information Specialist. Part of the “Strategy, Policy, and Market Access” team, he is responsible for maintaining and developing MPP’s Patents and Licences Database MedsPaL and performing patent searches and analyses. He holds a master’s degree in chemical engineering and biotechnology from the Swiss Federal Technology Institute of Lausanne (EPFL). Before joining MPP, Dana worked for over three years at PricewaterhouseCoopers as a consultant. Their main activities involved advising pharmaceutical and life sciences companies on access strategies for innovative pharmaceutical drugs, medical devices, and technologies.
Access Officer
Senior Manager, Access, Non-Communicable Diseases (NCDs)
[5/25 11:41 AM] Giulia Segafredo
Giulia Segafredo joined the Medicines Patent Pool in 2020 and currently leads the work on the non-communicable diseases (NCDs) and maternal health portfolio within the Strategy, Policy, and Access team. In this role, she plays a key role in selecting priority medicines for in-licensing and partnering with key global organisations to align priorities and catalyse market-shaping efforts for in-licensed candidates.
Giulia brings substantial experience in drug development and market access from her time in the pharmaceutical industry, coupled with extensive health system strengthening program management in low- and middle-income countries. She has managed several public health and operational research projects on nutrition, maternal health and on the intersection between infectious and non-communicable diseases in several countries in sub-Saharan Africa, such as South Sudan, Angola, Tanzania, Ethiopia and Mozambique.
She holds a master’s degree in Pharmaceutical Chemistry and Technologies, a PhD in Epidemiology and Public Health, and is a registered pharmacist.
Patent Information Officer
Zongyuan Tang joined the Medicines Patent Pool in December 2021 as Patent Information Officer. A member of the Policy and Advocacy team, she supports the Patent Information Manager, and is responsible for medicines, vaccines, patents data entry and management, collecting information on pharmaceutical test data exclusivity, preparing listings of patents and patents applications and contributing to the further development of MedsPal and VaxPal databases. Prior to joining MPP, Zongyuan worked for the World Intellectual Property Organization for two years and a half in the Madrid Information System Division, Madrid Registry, Brands and Designs Sector, based in Geneva. Zongyuan holds a master’s degree in Business Administration and a double bachelors’ degree in Business Administration and Management from the Webster University of Geneva.
Technology Transfer Director (Executive Leadership Team)
Ike James, our Technology Transfer Director (Executive Leadership Team) joined MPP in March 2022 within the Technology Transfer Unit. He has the overall responsibility for overseeing MPPs work in technology transfer, local production in low- and middle-income countries and its role in the ACT-A/COVAX Manufacturing Workforce. Ike has held technical leadership positions at Biovac, Aspen Pharmacare, and Lonza prior to starting at MPP, culminating in approximately 16 years’ experience in the pharmaceutical industry. He has focused on the product development, technology transfer, and process validation of small molecules and biological products, together with the operationalisation of new state of the art manufacturing facilities, ensuring the successful commercial launch thereof and compliance to quality and regulatory requirements. Ike holds a PhD in Chemical Engineering from Stellenbosch University, South Africa.
Biologic Health Products Expert
Landry Bertaux joined the Medicines Patent Pool in February 2022 as Biologic Health Products Expert within the Technology Transfer Unit. Before joining MPP, Landry worked for 17 years at Sanofi Pasteur in Formulation and Drug Substance Process Development before leading the CMC activities (Manufacturing, Testing and associated Regulatory and Quality) for New Vaccines in Development. Landry holds a Master of Science in Biotechnology from the European High School of Biotechnology (Germany, Switzerland, France) and a Master’s degree in Molecular and Cellular Biology from the Strasbourg University (France).
Project Manager
Julien Bon joined the Medicines Patent Pool in May 2023 as Project Manager within the Technology Transfer Unit. Before joining MPP, Julien worked for 15 years for the biopharma industry in the management of operations and contract manufacturers for the production of biologics. Julien holds a Master of Science in Biotechnology from the Polytechnic Institute of Bordeaux (France).
Programme Manager, Technology Transfer
Monica Moschioni joined MPP in March 2022 as Project Manager within the newly created Technology Transfer Unit. Before joining MPP, Monica worked for six years at Médecins Sans Frontières (MSF) on two multi-country MDR-TB Phase III clinical trials sponsored by MSF (TB-PRACTECAL and endTB) as Country Coordinator and Trial Manager. Before MSF, Monica worked for 15 years at Novartis Vaccines and GSK Vaccines in the Research and Development Department leading vaccine coverage evaluation projects in high -, low- and middle-income countriesfor vaccines in early or late development phase. Monica holds a PhD in Molecular Biology from Bologna University (Italy), a Master in Public Health from the London School of Hygiene and Tropical Medicine (UK) and a Master of Science in Pharmacy from the University of Padova (Italy).
Technology Transfer Expert
Umut Demirtas joined the Medicines Patent Pool in May 2025 as Technology Transfer Expert within the Technology Transfer Unit. Before joining MPP, Umut worked 15 years in process development and manufacturing of several biopharmaceutical companies. He has worked on broad range of products for successful commercialization starting from early-stage development to scale up and technology transfer between multiple sites. Umut holds an Engineering Doctorate in Bioproduct Design from Technical University of Delft (The Netherlands).